Impact of Early Molecular Response in Children With Chronic Myeloid Leukemia Treated in the French Glivec Phase 4 Study

Blood - United States
doi 10.1182/blood-2014-05-578567
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Hematology

Related search

Long-Term Impact of Molecular Response Fluctuations in Chronic Myeloid Leukaemia Patients Treated With Imatinib

British Journal of Haematology
Hematology
2017English

Long-Term Molecular Responses to Imatinib in Patients With Chronic Myeloid Leukemia: Comparison Between Complete Cytogenetic Responders Treated in Early and in Late Chronic Phase

Haematologica
Hematology
2007English

Pleural Effusion in Dasatinib-Treated Patients With Chronic Myeloid Leukemia in Chronic Phase: Identification and Management

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2017English

New Tool for Monitoring Molecular Response in Chronic Myeloid Leukemia.

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2015English

Discontinuation of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: Recommendations for Clinical Practice From the French Chronic Myeloid Leukemia Study Group

Cancer
Cancer ResearchOncology
2018English

Imatinib Pharmacokinetics and Its Correlation With Response and Safety in Chronic-Phase Chronic Myeloid Leukemia: A Subanalysis of the IRIS Study

Blood
BiochemistryImmunologyCell BiologyHematology
2008English

Management of Chronic Myeloid Leukemia in Advanced Phase

Frontiers in Oncology
Cancer ResearchOncology
2019English

Effect of Tyrosine Kinase Inhibitor in Patients With Chronic Myeloid Leukemia (Cytogenetic, Molecular Response) in Mosul

Annals of the College of Medicine, Mosul
2018English

Differential Depth of Treatment Response Required for Optimal Outcome in Patients With Blast Phase Versus Chronic Phase of Chronic Myeloid Leukemia

Blood Cancer Journal
OncologyHematology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy